What causes cga

What is Chronic Granulomatous Disease (CGD)?

Chronic Granulomatous Disease (CGD), previously known as 'chronic granulomatous disease', is a rare primary immunodeficiency disorder. It is characterized by the inability of certain white blood cells, specifically phagocytes (like neutrophils and macrophages), to effectively kill certain types of bacteria and fungi. These phagocytes are crucial components of the immune system, tasked with engulfing and destroying invading microorganisms. In individuals with CGD, a defect in a specific enzyme pathway within these cells prevents them from producing reactive oxygen species (ROS), often referred to as a 'respiratory burst'. This process is essential for killing ingested pathogens.

What Causes CGD?

The root cause of CGD lies in genetic mutations. These mutations affect the genes that code for components of the NADPH oxidase enzyme complex. This enzyme complex is responsible for generating the reactive oxygen species (ROS) that are vital for killing pathogens within phagocytes. There are several genes involved in this complex, and mutations in any of them can lead to CGD. The most common form of CGD, accounting for approximately 65% of cases, is X-linked, meaning the mutation occurs on the X chromosome. This form is primarily seen in males, though it can affect females in rare instances. Autosomal recessive forms of CGD also exist, where mutations occur on non-sex chromosomes, and these can affect both males and females.

The Role of the NADPH Oxidase Complex

The NADPH oxidase enzyme complex is a multi-component system located in the membrane of phagocytes. When a phagocyte encounters a bacterium or fungus, it engulfs it into a vesicle called a phagosome. The cell then activates the NADPH oxidase complex, which uses nicotinamide adenine dinucleotide phosphate (NADPH) as a source of electrons to reduce molecular oxygen to superoxide radicals. These superoxide radicals are then converted into other reactive oxygen species, such as hydrogen peroxide. These ROS are highly toxic and work by damaging the cell membranes, DNA, and proteins of the ingested microbes, effectively killing them. In CGD, the malfunctioning or absent NADPH oxidase complex cannot produce these ROS, leaving the phagocytes unable to clear the infection effectively.

Inheritance Patterns of CGD

CGD is inherited, meaning it is passed down through families via genes. Understanding the inheritance pattern is crucial for diagnosis and genetic counseling.

X-Linked CGD

This is the most common form, accounting for about 65% of all CGD cases. The gene responsible for a subunit of the NADPH oxidase complex (the gp91-phox subunit) is located on the X chromosome. Because males have only one X chromosome (XY), a mutation on this chromosome directly causes the disease. Females have two X chromosomes (XX), and typically, the normal gene on one X chromosome can compensate for the defective gene on the other. However, in rare cases, a phenomenon called skewed X-inactivation can occur in females, where the X chromosome with the normal gene is randomly inactivated in a significant proportion of cells, leading to symptoms of CGD.

Autosomal Recessive CGD

These forms of CGD are less common and result from mutations in genes located on non-sex chromosomes (autosomes). For autosomal recessive inheritance, an individual must inherit a mutated gene from both parents to develop the disorder. If a person inherits only one mutated gene, they are a carrier but usually do not show symptoms. Several genes can be involved in the autosomal recessive forms, including those coding for the p47-phox, p67-phox, and p40-phox subunits of the NADPH oxidase complex.

Symptoms and Manifestations of CGD

The consequences of the impaired immune response in CGD manifest as recurrent and severe infections. These infections can affect various parts of the body, including the lungs, skin, lymph nodes, liver, and bones. Common pathogens that cause serious illness in individuals with CGD include species of Staphylococcus, Serratia marcescens, Nocardia, Burkholderia cepacia, and the fungi Aspergillus* species. Children with CGD may experience:

• Recurrent pneumonia
• Skin abscesses
• Swollen lymph nodes
• Enlarged liver or spleen
• Bone infections (osteomyelitis)
• Chronic diarrhea

In addition to infections, individuals with CGD can also develop inflammatory conditions known as 'granulomas'. These are collections of immune cells that form in an attempt to wall off persistent infections or foreign materials, but in CGD, they can lead to organ damage and dysfunction.

Diagnosis and Management

Diagnosing CGD typically involves a combination of clinical evaluation and specific laboratory tests. The cornerstone of diagnosis is the dihydrorhodamine (DHR) 123 test, which measures the production of ROS by phagocytes. Genetic testing can confirm the specific gene mutation and inheritance pattern. Management of CGD focuses on preventing infections and treating them promptly when they occur. This often includes prophylactic antibiotics and antifungals, as well as prompt treatment of any active infections. Interferon-gamma therapy has also been shown to reduce the frequency of serious infections in CGD patients. In severe cases, a hematopoietic stem cell transplantation (HSCT) is the only potential cure for CGD.

Living with CGD

While CGD is a serious condition, advances in diagnosis and treatment have significantly improved the outlook for affected individuals. With proper medical care, lifelong management, and vigilant monitoring, many people with CGD can lead relatively normal and fulfilling lives. However, it requires ongoing medical supervision and adherence to treatment regimens.